Insider: Miller Joseph M Chief Financial Officer - Aurinia Pharmaceuticals Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 577,361 | 0 | 577,361 |
| Value | $7,586,523.54 | $0.00 | $7,586,523.54 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/04/2025 | DDS | 56,154 | Direct | COM | $7.92 | $444,739.68 | 577,361 |
| 03/03/2025 | DDS | 61,859 | Direct | COM | $8.00 | $494,872.00 | 633,515 |
| 03/06/2024 | DDS | 34,811 | Direct | COM | $5.60 | $194,941.60 | 495,928 |
| 03/02/2023 | DDS | 11,296 | Direct | COM | $8.94 | $100,986.24 | 331,214 |
| 03/02/2022 | DDS | 3,060 | Direct | COM | $12.01 | $36,750.60 | 6,610 |
| 05/11/2021 | AAP | 1,000 | Direct | COM | $9.74 | $9,740.00 | 1,000 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research